Latest Public Service Radio Minute
Loss of EmploymentLoss of Employment, MP3, 1.3MB
Listen to or download all our PSAsSupport Our Work
Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!
More InfoLatest News Around the Web
Researchers Examine Association Between Back Pain, Mental Health, And Substance Use In Adolescents
Healio (10/31, Miller) reports, “Adolescents with more frequent back pain were also more likely to report anxiety and depression, and more likely to smoke and drink alcohol,” research indicated. The findings of the 6,388-teen study were published online Sept. 10 in the Journal of Public Health.
Related Links:
— “Researchers Examine Association Between Back Pain, Mental Health, And Substance Use In Adolescents, “Janel Miller, Healio, October 31, 2018.
Medications Acting On Brain’s Neurotransmitters Taken During Pregnancy Appear Not To Have An Association With Offspring’s Risk For Autism, Study Indicates.
HealthDay (10/31, Preidt) reports, “Many pregnant women may wonder if antidepressants – or other drugs acting on the brain’s neurotransmitters – might raise their” infants’ “odds of developing autism.” A new study “suggests that’s not the case.” However, “a mother’s health before and during pregnancy may play a role in autism spectrum disorders,” researchers concluded after evaluating “the risks associated with 180 medications that target neurotransmitters, including antidepressants and antipsychotics,” using “data from nearly 100,000 children born in Israel between 1997 and 2007.” The findings were published online Oct. 31 in JAMA Psychiatry.
According to MedPage Today (10/31, George), the authors of an accompanying editorial wrote, “It would be hasty to conclude that specific drug classes have no associations with autism because there may be other mechanisms at play.” The editorialists added, “Further, it is important to recognize that a full profile of the pharmacological properties of many of the drugs examined in this study is still unknown.” Healio (10/31, Demko) also covers the study.
Related Links:
— “Autism Risk: Mom’s Health May Matter More Than Meds, ” Robert Preidt, HealthDay, October 31, 2018.
Teens, Young Adults Who Use Cannabis May Find It Harder To Learn, Small Study Indicates
Newsweek (10/30, Gander) reports, “Teenagers and young adults who use cannabis could find it harder to learn,” research indicated. Quitting the substance, however, “was found to boost the memory of regular users after one month.” Included in the study were “88 teenagers and young adults, between the ages of 16 to 25 years old, who used cannabis at least once a week.” The young people “who stopped using the drug appeared to improve at learning new information after only one week,” while “the control group experienced no change.” The findings were published online Oct. 30 in the Journal of Clinical Psychiatry.
According to the NPR (10/30, Cohen) “Shots” blog, “more than 14 percent of middle and high school students reported using marijuana within the last month, finds a National Institutes of Health surveyconducted” last year. What’s more, “marijuana use has increased among high schoolers over the past 10 years, according to the U.S. Department of Health & Human Services.” Also covering the story are U.S. News & World Report (10/30, Hansen) and HealthDay (10/30, Thompson).
Related Links:
— “Cannabis Study: Memory and learning Improve When Teens Quit Smoking , “Kashmira Gander, Newsweek , October 30, 2018.
Both Prolonged Exposure And Sertraline Appear To Show Good Short- And Long-term Efficacy Across A Range Of Outcomes, Small Study Indicates
Healio (10/30, Demko) reports, “Both prolonged exposure and sertraline showed good short- and long-term efficacy across a range of outcomes among patients with” post-traumatic stress disorder (PTSD), research indicated. What’s more, “patients with PTSD who selected their form of treatment – prolonged exposure or sertraline – showed more improvement than those who were prescribed one or the other regardless of preferences,” the study revealed. The findings of the 200-patient, “doubly randomized preference trial” were published online Oct. 19 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.
Related Links:
— “Patient treatment preference plays role in improving PTSD outcomes, “Savannah Demko, Healio, October 30, 2018.
Young People Who Spend Long Hours On Screens May Be More Than Twice As Likely To Be Diagnosed With Depression Or Anxiety Than Those Who Use Screens For An Hour A Day, Research Suggests
TIME (10/29, Heid) reports, “Young people who spend seven hours or more a day on screens are more than twice as likely to be diagnosed with depression or anxiety than those who use screens for an hour a day,” researchers concluded after examining data “from more than 40,000 kids ages two to 17” that “was collected as part of the Census Bureau’s 2016 National Survey of Children’s Health.” The findings were published online Oct. 18 in the journal Preventive Medicine Reports.
Related Links:
— “There’s Worrying New Research About Kids’ Screen Time and Their Mental Health, “Markham Heid, TIME, October 29, 2018.
Foundation News
Nothing Found
It seems we can’t find what you’re looking for. Perhaps searching can help.

